126 related articles for article (PubMed ID: 14710439)
1. Pulmonary deposition of monodisperse aerosols in patients with chronic obstructive pulmonary disease.
Meyer T; Müllinger B; Sommerer K; Scheuch G; Brand P; Beckmann H; Häussinger K; Weber N; Siekmeier R
Exp Lung Res; 2003; 29(7):475-84. PubMed ID: 14710439
[TBL] [Abstract][Full Text] [Related]
2. Alveolar deposition of monodisperse aerosol particles in the lung of patients with chronic obstructive pulmonary disease.
Brand P; Meyer T; Sommerer K; Weber N; Scheuch G
Exp Lung Res; 2002; 28(1):39-54. PubMed ID: 11792074
[TBL] [Abstract][Full Text] [Related]
3. Optimum peripheral drug deposition in patients with cystic fibrosis.
Brand P; Meyer T; Häussermann S; Schulte M; Scheuch G; Bernhard T; Sommerauer B; Weber N; Griese M
J Aerosol Med; 2005; 18(1):45-54. PubMed ID: 15741773
[TBL] [Abstract][Full Text] [Related]
4. Ultrafine particle deposition and clearance in the healthy and obstructed lung.
Brown JS; Zeman KL; Bennett WD
Am J Respir Crit Care Med; 2002 Nov; 166(9):1240-7. PubMed ID: 12403694
[TBL] [Abstract][Full Text] [Related]
5. Effect of Posture on Regional Deposition of Coarse Particles in the Healthy Human Lung.
Sá RC; Zeman KL; Bennett WD; Prisk GK; Darquenne C
J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):423-31. PubMed ID: 25826480
[TBL] [Abstract][Full Text] [Related]
6. The effect of biphasic inhalation profiles on the deposition and clearance of coarse (6.5 microm) bolus aerosols.
Clark AR; Chambers CB; Muir D; Newhouse MT; Paboojian S; Schuler C
J Aerosol Med; 2007; 20(1):75-82. PubMed ID: 17388755
[TBL] [Abstract][Full Text] [Related]
7. Comparative performance of two inhaler systems to assess distribution of convective ventilation by 99mTc-labeled aerosol scintigraphy in patients with airway obstruction.
Fazzi P; Borsò E; Albertelli R; Mariani G; Giuntini C
Q J Nucl Med Mol Imaging; 2009 Aug; 53(4):428-36. PubMed ID: 19174757
[TBL] [Abstract][Full Text] [Related]
8. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.
Kolanjiyil AV; Kleinstreuer C; Sadikot RT
Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120
[TBL] [Abstract][Full Text] [Related]
9. [Pilot Project: Improved Lung Deposition via a New Nasal Inhalation Procedure].
Mursina L; Groß V; Librizzi D; Luster M; Sohrabi A; Seifert O; Hildebrandt O; Heverhagen JT; Koehler U; Sohrabi K
Pneumologie; 2015 Aug; 69(8):469-76. PubMed ID: 26258421
[TBL] [Abstract][Full Text] [Related]
10. SPECT/CT study of bronchial deposition of inhaled particles. A human aerosol vaccination model against HPV.
Ilic V; Dunet V; Le Pape A; Buchs M; Kosinski M; Bischof Delaloye A; Gerber S; Prior JO
Nuklearmedizin; 2016 Sep; 55(5):203-8. PubMed ID: 27440125
[TBL] [Abstract][Full Text] [Related]
11. Effects of inhaled iron oxide particles on alveolar epithelial permeability in normal subjects.
Lay JC; Zeman KL; Ghio AJ; Bennett WD
Inhal Toxicol; 2001 Dec; 13(12):1065-78. PubMed ID: 11696874
[TBL] [Abstract][Full Text] [Related]
12. Selective deposition of inhaled aerosols to mechanically ventilated rabbits.
Dahlbäck M; Wollmer P; Jonson B
J Aerosol Med; 1994; 7(4):315-24. PubMed ID: 10150485
[TBL] [Abstract][Full Text] [Related]
13. Deposition, retention, and translocation of ultrafine particles from the central airways and lung periphery.
Möller W; Felten K; Sommerer K; Scheuch G; Meyer G; Meyer P; Häussinger K; Kreyling WG
Am J Respir Crit Care Med; 2008 Feb; 177(4):426-32. PubMed ID: 17932382
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the generation of radiolabeled monodisperse albuterol particles using the spinning-top aerosol generator.
Usmani OS; Biddiscombe MF; Underwood SR; Barnes PJ
J Nucl Med; 2004 Jan; 45(1):69-73. PubMed ID: 14734675
[TBL] [Abstract][Full Text] [Related]
15. Regional deposition of inhaled hygroscopic aerosols: in vivo SPECT compared with mathematical modeling.
Finlay WH; Stapleton KW; Chan HK; Zuberbuhler P; Gonda I
J Appl Physiol (1985); 1996 Jul; 81(1):374-83. PubMed ID: 8828688
[TBL] [Abstract][Full Text] [Related]
16. Deposition of inspired aerosol particles within the respiratory tract of patients with obstructive lung disease.
Schiller-Scotland CF; Gebhart J; Hochrainer D; Siekmeier R
Toxicol Lett; 1996 Nov; 88(1-3):255-61. PubMed ID: 8920746
[TBL] [Abstract][Full Text] [Related]
17. Inhalation of [123I]alpha1-protease inhibitor: toward a new therapeutic concept of alpha1-protease inhibitor deficiency?
Kropp J; Wencker M; Hotze A; Banik N; Hübner GE; Wunderlich G; Ulbrich E; Konietzko N; Biersack HJ
J Nucl Med; 2001 May; 42(5):744-51. PubMed ID: 11337570
[TBL] [Abstract][Full Text] [Related]
18. Aerosol deposition and clearance measurement: a novel technique using dynamic SPET.
Eberl S; Chan HK; Daviskas E; Constable C; Young I
Eur J Nucl Med; 2001 Sep; 28(9):1365-72. PubMed ID: 11585296
[TBL] [Abstract][Full Text] [Related]
19. Computational Models of Inhalation Therapy in Early Childhood: Therapeutic Aerosols in the Developing Acinus.
Katan JT; Hofemeier P; Sznitman J
J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):288-98. PubMed ID: 26907858
[TBL] [Abstract][Full Text] [Related]
20. Altered deposition of inhaled nanoparticles in subjects with chronic obstructive pulmonary disease.
Jakobsson JKF; Aaltonen HL; Nicklasson H; Gudmundsson A; Rissler J; Wollmer P; Löndahl J
BMC Pulm Med; 2018 Aug; 18(1):129. PubMed ID: 30081885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
